Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Syngene International Ltd. is an innovation-focused global contract research, development, and manufacturing organization (CRDMO) providing integrated scientific services. Headquartered in Bengaluru, India, Syngene supports R&D programs from discovery to commercial supply for pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical companies worldwide. Their comprehensive service offerings include drug discovery and development, API manufacturing, biologics research and manufacturing, formulation development, and clinical development services, enabling clients to accelerate their R&D pipelines and bring innovative products to market efficiently.
The Bengaluru headquarters is the nerve center for Syngene's global operations, housing advanced R&D laboratories, cGMP-compliant manufacturing plants for small and large molecules, and corporate functions. It facilitates end-to-end integrated service delivery.
The campus features state-of-the-art R&D infrastructure, dedicated Centers of Excellence for various scientific disciplines, advanced analytical capabilities, commercial-scale biologics manufacturing, and a strong focus on safety, quality, and sustainability (e.g., green chemistry initiatives, high EHS standards).
Syngene fosters a science-driven, collaborative, and client-centric work environment. The culture emphasizes quality, integrity, innovation, continuous learning, and employee development, attracting a diverse and highly skilled workforce.
The Bengaluru headquarters is strategically vital for Syngene's integrated ' molécule to market' service model. It centralizes diverse capabilities, enabling seamless project execution and leveraging India's scientific talent and cost-efficiencies for global clients.
Syngene International Limited serves a diverse global clientele, including leading pharmaceutical, biotechnology, agrochemical, consumer health, animal health, and specialty chemical companies across North America, Europe, Japan, Australia, and other regions. While its core research, development, and manufacturing operations are strategically located in India (Bengaluru, Hyderabad, Mangaluru), Syngene maintains international business development offices in key markets such as the USA (Cambridge, MA) and the UK (Cheshire). This global network ensures localized client support, effective project management, and the ability to deliver integrated scientific solutions worldwide, contributing to innovation across multiple industries.
Biocon Park, Plot Nos 2 & 3, Bommasandra Phase IV, Jigani Link Road
Bengaluru
Karnataka
India
Address: Syngene International Limited, Plot No. 29, S.P. Biotech Park, Phase - III, Turkapally Village, Shameerpet Mandal, Medchal-Malkajgiri District, Hyderabad – 500 101, Telangana, India
Serves as a significant R&D and services hub, complementing the Bengaluru operations and tapping into Hyderabad's rich pharmaceutical and biotech ecosystem.
Address: Syngene International Ltd., Plot No. 1A & 1B, Mangalore Special Economic Zone (MSEZ), Bajpe, Mangaluru - 574 142, Karnataka, India
Acts as a key commercial manufacturing site, strategically located within an SEZ to facilitate export-oriented production and leverage port connectivity for efficient logistics.
Address: Syngene USA Inc., One Broadway, 14th Floor, Cambridge, MA 02142, USA
Strengthens Syngene's presence in the vital North American market, providing local support and fostering collaborations within one of the world's largest biotech clusters.
Address: Syngene Europe Limited, BioHub, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
Enhances Syngene's footprint in the European market, allowing for closer collaboration with pharmaceutical companies, biotech firms, and research institutions across the UK and continental Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Syngene International Limited' leadership includes:
Syngene International Limited has been backed by several prominent investors over the years, including:
Over the last 12 months (May 2023 - May 2024), Syngene International Limited experienced a key leadership transition in its finance department with the appointment of a new Chief Financial Officer.
Discover the tools Syngene International Limited uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Syngene International Limited typically uses a standard corporate email format. The most common patterns involve combinations of an employee's first name and last name, or first initial and last name, followed by the company domain '@syngeneintl.com'.
Common formats are [first].[last]@syngeneintl.com (e.g., john.doe@syngeneintl.com) and [first_initial][last]@syngeneintl.com (e.g., jdoe@syngeneintl.com).
Format
john.doe@syngeneintl.com
Example
70%
Success rate
Business Standard • April 24, 2024
Syngene International reported a 6% year-on-year increase in its consolidated net profit to Rs 189 crore for the fourth quarter ended March 2024. The company's revenue from operations saw an 8% rise to Rs 917 crore, attributed to strong performance in its Development and Manufacturing services divisions....more
The Economic Times • November 28, 2023
Syngene International announced a strategic collaboration with US-based Zumutor Biologics Inc. The partnership aims to advance Zumutor's lead oncology molecule, ZM008, an antibody-drug conjugate (ADC), through integrated drug substance and drug product development, along with cGMP manufacturing....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Syngene International Limited, are just a search away.